Sunday, 9 June 2013

Renvela


Renvela

Generic name/Active ingredient: sevelamer carbonate 800 mg
Trade name: Renvela
Dosage form: Tablets
Drug classification: Phosphate binder
Legal classification: POM
Company: sanofi aventis
Commonly used for: Control of hyperphosphatemia in adult patients on hemo- or peritoneal dialysis or w/ chronic kidney disease (CKD) not on dialysis w/ serum P ≥1.78 mmol/L